Biomagnetics identifies second biomarker for tuberculosis assay Biomagnetics Diagnostics Corp.

Biomagnetics identifies second biomarker for tuberculosis assay Biomagnetics Diagnostics Corp., a developer of groundbreaking diagnostic systems and technology for HIV, hepatitis, tuberculosis, malaria and cholera detection, and additional innovative technologies, announced the identification of another biomarker for advancement of a tuberculosis assay today. This is a substantial milestone in the cooperative analysis contract that was signed between Los Alamos National Laboratory and Biomagnetics, representing a significant step in the advancement of a fresh point-of-care diagnostic program http://snovitra.com . In parallel, advancement of assays for just two different tuberculosis biomarkers and the Cholera toxin happens to be in progress.

http://www.snovitra.com/

Biomet provides description to FDA regarding advertising rights for Signature Personalized Individual Care system Biomet received a Caution Letter from the U.S. The business hasn’t received a formal response to its August 3rd letter to the FDA. Biomet is focused on dealing with the FDA to solve the concern in the very best interests of individuals and their doctors without disruption to individual treatment.

Random entries

Other entries from category "pediatrics":